Emtricitabine
Paul A. Pham, Pharm.D., John G. Bartlett, M.D., Alice Jenh Hsu, Pharm.D.
Emtricitabine is a topic covered in the
Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --
INDICATIONS
- Treatment of HIV infection in combination with other antiretroviral agents.
- Treatment of hepatitis B in HIV-HBV co-infected patients
- Post-exposure prophylaxis (PEP) in combination with other agents
- Pre-exposure prophylaxis (PrEP) with tenofovir disoprixil fumarate
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
- Treatment of HIV infection in combination with other antiretroviral agents.
- Treatment of hepatitis B in HIV-HBV co-infected patients
- Post-exposure prophylaxis (PEP) in combination with other agents
- Pre-exposure prophylaxis (PrEP) with tenofovir disoprixil fumarate
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved